The Non-Financial Ledger: What Numbers Cannot Measure

There is a person on the other end of every share of stock. That person is not a hedge fund algorithm or a research analyst with a Bloomberg terminal. That person is a teacher with a pension fund, a hospital worker whose 401(k) is managed by an institution that trusted ADM’s filings, a retiree who bought shares because a company promising 15 to 20 percent annual growth in a food technology segment sounded like exactly the kind of safe, future-oriented bet you make when you cannot afford to lose.

Vikram Luthar knew who was in that category. He had been Head of Investor Relations at ADM. His entire job, for a stretch of his career, was to look investors in the face and tell them why ADM deserved their money. He knew how the story worked. He knew that analysts were citing Nutrition’s growth trajectory as a reason to assign ADM a higher valuation. He knew that major institutional investors had built their ADM position on the assumption that those Nutrition numbers were real.

And he knew — because the SEC complaint is explicit about this — that the numbers were not real.

The moment that hits hardest is not in the financial tables. It is in the internal message where Nutrition’s President, under pressure from Luthar to keep finding ways to juice the numbers, eventually breaks and tells the presidents of AS&O and CarbSol, “in good conscience, you guys have both already done too much for us.” That sentence is an admission. It means even the people running the scheme knew they had crossed a line. It means the transfers were not accounting adjustments; they were favors extracted under duress from colleagues who had their own performance bonuses tied to helping Nutrition look good.

It also means that when Luthar stood on earnings calls in October 2022 and January 2023 and told investors that Nutrition had “continued its strong growth trajectory” and that the issues affecting Q4 were “a little more temporary,” he was not making an honest mistake. He was aware that the Controller had been pressured into reversing her own objections. He was aware that the AS&O president had called the arrangement “begging for money” and declared “the charitable bank is closed.” He chose to describe none of that to the people whose retirement savings were sitting in ADM stock.

On January 22, 2024, those people woke up to a 24 percent drop in a single day. One large institutional investor, holding a significant long-term stake in ADM, sold its entire position. It described what it felt as a “crisis in confidence.” That phrase means something specific in the language of institutional investing. It means the numbers you built your thesis on cannot be trusted. It means years of research and due diligence are now worthless. For the individual investor, it just means the money is gone.

At the close of trading on November 18, 2024, the day ADM filed its restated financials, the stock was still more than 23 percent below where it had been before the disclosure. That gap — the distance between where ordinary shareholders thought their investment was and where it actually ended up — is the price the public paid for Luthar’s $130,000 bonus and his $1.8 million in stock sales.

None of that appears in a line item. None of it gets restated. The restatement fixes the numbers on paper. It does not fix the account balances of the people who sold at the bottom, or who held through the collapse because they had been told, by the CFO himself, that things were “a little more temporary.”

Legal Receipts: What They Actually Said

The following are verbatim statements and documented facts drawn directly from the SEC complaint filed January 27, 2026 (Case 1:26-cv-00927). Each quote is followed by a breakdown of what it proves.

“Nutrition’s President told Luthar that AS&O’s President ‘is willing to work with us on white flake too. We spoke privately last night and he is severely motivated by [ADM’s Performance Incentive Plan] and [Performance Share Units] to help us.'”

— SEC Complaint, Paragraph 59

“Nutrition’s President expressed concern to Luthar about calling the adjustment a ‘rebate.’ Nutrition’s President told Luthar that it sounded like AS&O was giving Nutrition a ‘gift.’ Luthar agreed and stated that he preferred a less suspicious term for the adjustment: ‘risk sharing.'”

— SEC Complaint, Paragraph 68

“In good conscience, you guys have both already done too much for us.”

— Nutrition’s President to AS&O’s and CarbSol’s Presidents, SEC Complaint, Paragraph 80

“I get the impression [Luthar] is pretty angry with me” and “I cant (sic) take many more angry calls I had been warning everyone about this.”

— ADM’s Controller, SEC Complaint, Paragraph 92

“The Nutrition business continued its strong growth trajectory in 2022… continued to outperform industry growth levels and delivered 11% higher profits for the full year on a constant currency basis.”

— Vikram Luthar, ADM January 2023 Earnings Call, SEC Complaint, Paragraph 98

“In terms of Q4, the issues that affected Q4, I’d say, are kind of a little more temporary.”

— Vikram Luthar, responding to an analyst’s question about “structural challenges” in Nutrition, January 2023 Earnings Call, SEC Complaint, Paragraph 98

Societal Impact Mapping: Who Actually Paid the Price

Public Health of Markets and Financial Trust

When a company’s CFO certifies false financial statements, the damage extends far beyond a single stock price. The entire mechanism by which ordinary people participate in capital markets depends on the assumption that disclosed numbers are real. This case documents specific, traceable harms to that system.

• Retail investors and pension funds holding ADM stock on January 19, 2024 absorbed a 24 percent one-day loss when the fraud was disclosed, a loss that Luthar had already pre-empted by selling his own shares at inflated prices months earlier.
• At least one major institutional investor, holding a “significant, long-term stake” in ADM, sold its entire position after the disclosure and cited a “crisis in confidence” in ADM’s ability to accurately report its financials. Investors who had not yet sold at that point bore the full impact of that institutional exit depressing the price further.
• Multiple investment analysts were forced to lower their price targets and ratings for ADM after the disclosure, with one firm cutting its Capital Allocation Rating from “Exemplary” to “Standard” and stating it could no longer determine whether ADM’s acquisitions that created the Nutrition business had created any value at all.
• ADM was forced to delay its FY 2023 earnings release and its FY 2023 Form 10-K filing, meaning investors in the company had no reliable, current financial data for an extended period following the disclosure.
• The market for ADM notes sold to investors in September 2021, February 2022, and March 2023 was also affected; those offerings were made using registration statements that incorporated the fraudulent Nutrition performance figures.
• By November 18, 2024, when ADM filed the restated financials covering FY 2018 through FY 2023, the stock was still more than 23 percent below its pre-disclosure level. Shareholders who held through the restatement process did not recover their losses on paper during that entire period.

Economic Inequality: The Asymmetry of Who Wins and Who Loses

The financial structure of this scheme created a direct transfer of economic benefit from ordinary investors to a senior executive who had the access and information to time his exits. The mechanics of that transfer are documented in the complaint.

• Luthar sold 7,500 shares on June 7, 2022 at $89.59 per share for proceeds of $671,925, while simultaneously directing employees to find $10 to $20 million in new intersegment adjustments to keep the inflation going into FY 2022.
• Luthar sold 14,750 shares on February 13, 2023 for proceeds of $1,210,828, just days before certifying the FY 2022 Form 10-K that contained the fraudulent Nutrition figures his scheme had produced. His total stock sale proceeds were $1,882,753.
• On top of his stock sales, Luthar collected a $130,000 cash bonus tied directly to Nutrition’s FY 2021 performance, which it only appeared to meet because of the $20.7 million fraudulent white flake adjustment Luthar himself engineered.
• The executives of AS&O and CarbSol who were pressured into participating were also financially incentivized through ADM’s compensation plan to help Nutrition, meaning ADM’s own bonus structure distributed pressure down through the organization in a way that made resistance personally costly and compliance personally rewarding.
• Employees and middle managers at AS&O and CarbSol widely understood that to be considered a “good corporate citizen” by senior management, they should be willing to hurt their own division’s numbers to help Nutrition. This created a workplace culture where honesty about segment performance was professionally penalized.
• The people with the least information and the least power — ordinary retail investors without access to the internal emails, the earnings call transcripts that omitted material facts, or the compensation incentive structures — were the last to know and the ones least able to exit before the collapse.

What You Were Told vs. What Was Hidden

Anatomy of the Profit Laundering Scheme

ADM told investors that all three of its business divisions traded with each other at fair market prices. The reality was a structured system in which two divisions acted as involuntary profit donors to a third, with the transfers disguised as “rebates” or “risk sharing.”

The “Cost of a Life” Metric: What the Numbers Translate To

Who Was Connected to Whom: The Corporate Web

What Now? Accountability, Watchlists, and Next Steps

The SEC filed its complaint on January 27, 2026. The case is active. Here is what is at stake, who to watch, and what you can do.

Named Defendant and Relief Sought

• Vikram Luthar, age 57, Chicago, Illinois. Former Nutrition CFO and ADM CFO. Agreed to resign effective September 30, 2024. The SEC is pursuing: a permanent bar from serving as officer or director of any public company; disgorgement of all ill-gotten gains with pre-judgment interest; civil monetary penalties; and reimbursement to ADM of bonuses and stock sale profits under Sarbanes-Oxley Section 304.
• ADM’s corporate leadership [REDACTED – Not individually named as defendants in source] has not been charged in this complaint. The complaint names Luthar alone, though it describes the participation of other ADM executives including the Nutrition President, the AS&O President, and the Controller.
• The SEC’s complaint explicitly states that “unless enjoined, Luthar is reasonably likely to engage in future violations of the federal securities laws,” which is the legal standard used to justify a permanent officer-director bar.

The Regulatory Watchlist

• U.S. Securities and Exchange Commission (SEC): Lead plaintiff in Case 1:26-cv-00927, Northern District of Illinois. The SEC’s Chicago Regional Office filed this action. Contact: Timothy Leiman, Timothy J. Stockwell, Ashley E. Dalmau Holmes, Arefa Patel at 175 W. Jackson Blvd., Suite 1450, Chicago, Illinois 60604. Phone: (312) 353-3790.
• U.S. Department of Justice (DOJ): The SEC’s referral powers mean a parallel criminal investigation is possible. The conduct described — knowing falsification of certified public filings, insider stock sales during a fraud — meets thresholds that have previously resulted in criminal referrals in securities fraud cases.
• Financial Accounting Standards Board (FASB): The complaint highlights failures in compliance with ASC 280 (Segment Reporting). ADM’s restatement acknowledged a material weakness in internal controls over intersegment sales. Audit standards and FASB guidance on segment reporting may be reviewed in the wake of this case.
• ADM’s Board of Directors and Audit Committee: The restated financials covered six fiscal years (FY2018–FY2023). The extent to which the board and its audit committee were aware of or failed to detect the scheme should be the subject of ongoing shareholder scrutiny.
• Public Company Accounting Oversight Board (PCAOB): ADM’s external auditors approved financial statements later found to contain material misstatements. The auditor’s role in the multi-year failure to detect these adjustments warrants examination.

What You Can Do: Mutual Aid and Grassroots Resistance

• If you held ADM stock between 2021 and January 2024: Contact a securities class action attorney. Class action suits following accounting fraud disclosures are common, and ordinary shareholders who suffered losses during the fraud period may have legal standing to recover damages. Search the court docket at PACER for Case 1:26-cv-00927 for updates.
• If you manage or participate in a pension fund or 401(k): Ask your plan administrator what exposure your fund had to ADM during the fraud period. Institutional investors have fiduciary duties to their beneficiaries and may have additional legal options.
• Demand executive compensation reform: This case shows exactly how tying every division’s bonus to a single segment’s performance creates a system-wide incentive to falsify results. Write to your congressional representatives and push for stricter SEC rules on compensation metric disclosure in public company filings.
• Support whistleblower protections: The SEC became aware of ADM’s practices through a voluntary document request, meaning someone raised concerns. The SEC’s whistleblower program (sec.gov/whistleblower) offers financial awards and legal protections for people who report securities violations. These programs only work if people know they exist and trust them.
• Follow the restatement: ADM filed its amended FY 2023 Form 10-K on November 18, 2024. The restated figures cover FY 2018 through FY 2023. Read the restatement disclosures yourself at SEC EDGAR. Compare Nutrition’s restated operating profit figures against the projections ADM gave investors in earnings calls. The gap is the fraud in numbers.
• Organize locally around food system power: ADM is one of the largest agricultural companies on earth. Its control over grain processing, supply chains, and food ingredients affects prices and access globally. Local food sovereignty organizing — community gardens, food co-ops, local purchasing campaigns — reduces dependence on companies whose financial reporting you cannot verify.